Firm Logo
412.471.4300

Blog: Breast Cancer

  • New Breast Cancer Drug Approved By FDA – Her 2 Positive Late Stage Breast Cancer

    March 22, 2017

    New Breast Cancer Drug Approved by FDA — HER-2 Positive Late Stage Breast Cancer Ado-trastuzumab emtansine, an antibody-drug conjugate marketed as Kadcyla, has been approved by the FDA to treat HER2-positive late-stage (metastatic) breast cancer.  The drug — known as T-DM1 during clinical trials — is indicated for patients who didn’t respond to treatment with […]

    Read More
  • Reconstructive Surgery Options For Women With Breast Cancer

    March 22, 2017

    Doctors Failing to Inform Women with Breast Cancer of Reconstructive Surgery Options The New York Times recently examined reconstructive breast surgery options provided to cancer patients undergoing mastectomies.   According to the Times, despite recent advances in reconstructive breast surgery procedures, many plastic surgeons are failing to inform women about the extent of their reconstruction […]

    Read More
  • Breast Cancer Don T Let Word Choice Influence Your Treatment Choice

    March 22, 2017

    Breast Cancer — Don’t Let Word Choice Influence Your Treatment Choice When doctors avoid using the word “cancer” in describing ductal carcinoma in situ (DCIS), women are more likely to choose nonsurgical treatment options, according to a research letter in JAMA Internal Medicine. Researchers presented some 400 healthy women with three scenarios in which DCIS was […]

    Read More
  • Lumpectomy Doesnt Increase Risk Of Breast Cancer Coming Back

    March 22, 2017

    Research on deciding whether to undergo lumpectomy or mastectomy indicates that lumpectomy does not increase risk of breast cancer coming back New research published in the March 2014 issue of JAMA Surgery titled “Breast Conserving Therapy for Triple-Negative Breast Cancer” indicates that lumpectomy does not increase the risk of the breast cancer coming back.  Triple […]

    Read More
  • Lymph Node Surgery Dependent On Experienced Surgeon And Hospital

    March 22, 2017

    Should you have extensive axillary lymph node dissection if you have Stage I breast cancer (DCIS)? Or should you only have sentinel lymph node surgery? A new study published in JAMA Oncology looked at whether experienced surgeons are more likely to do less extensive lymph node evaluation than less experienced surgeons, in patients with ductal […]

    Read More
  • Breast Cancer Featured In New York Times

    March 22, 2017

    Breast Cancer Featured in New York Times  October 21, 2008, the New York Times features an article with information on several aspects of breast cancer. If you suspect that your breast cancer was not timely and properly diagnosed or treated, please call us at 412-471-4300, or email us. At Berger & Lagnese, LLC, our lawyers specialize […]

    Read More
  • Studies Radiation To Lymph Nodes Doesnt Improve Survival

    March 22, 2017

    Should Women with Breast Cancer have radiation to your Lymph Nodes? Two New Studies conclude that it doesn’t improve overall survival, but it does reduce the risk of breast cancer recurrence. After surgery to remove breast cancer, many women have radiation to the breast area.  Also, many doctors recommend that women also have radiation to […]

    Read More
  • Treatment For Breast Cancer In Early Stages New Study

    March 22, 2017

    Treatment for breast cancer in early stages – new study New medical research suggests that in certain breast cancer patients, survival and prognosis are not benefited by removing axillary lymph nodes if there is a malignant sentinel node.  The study was presented at the recent meeting of the American Society of Clinical Oncology and found […]

    Read More
  • Family History Of Breast Cancer Doesnt Mean Worse Outcomes

    March 22, 2017

    Women with breast cancer who have a family history of breast cancer do not have worse outcomes than women without a family history of breast cancer. Women with close relatives who have been diagnosed with breast cancer have a higher risk of developing the disease.  However, a study found that young women with a family […]

    Read More
  • Women At High Risk Of Breast Cancer Benefit From Alternating Mri And Mammography

    March 22, 2017

    Women at High Risk of Breast Cancer Benefit from Alternating MRI and Mammography According to research conducted by doctors at the University of Texas M. D. Anderson Cancer Center, magnetic resonance imaging (MRI) alternated with mammography at six-month intervals can detect breast cancers not identified by mammography alone. MRI is known to be more sensitive […]

    Read More

We Have Successfully Handled Cases Like Yours